Insider Buying: PureTech Health (LON:PRTC) Insider Buys 65,250 Shares of Stock

PureTech Health plc (LON:PRTC) insider Sharon Barber-Lui bought 65,250 shares of the company’s stock in a transaction that occurred on Tuesday, September 23rd. The shares were bought at an average price of GBX 124 per share, for a total transaction of £80,910.

PureTech Health Trading Up 2.1%

PRTC opened at GBX 128 on Wednesday. PureTech Health plc has a 52-week low of GBX 100.40 and a 52-week high of GBX 178. The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82. The firm has a market capitalization of £309.36 million, a P/E ratio of 752.94 and a beta of 1.02. The firm’s 50 day moving average is GBX 129.15 and its 200-day moving average is GBX 129.62.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.